This company has been marked as potentially delisted and may not be actively trading.

Dynavax Technologies (DVAX) Stock Forecast & Price Target

Get the Latest News and Ratings for DVAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Dynavax Technologies and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DVAX Analyst Ratings Over Time

Type	Current Forecast 5/7/25 to 5/7/26	1 Month Ago 4/7/25 to 4/7/26	3 Months Ago 2/6/25 to 2/6/26	1 Year Ago 5/7/24 to 5/7/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$32.00	$21.00	$24.33	$24.00
Forecasted Upside	106.45% Upside	35.48% Upside	56.99% Upside	146.91% Upside
Consensus Rating	Hold	Reduce	Hold	Moderate Buy

DVAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DVAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Dynavax Technologies Stock vs. The Competition

Type	Dynavax Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	106.45% Upside	913.14% Upside	14.02% Upside
News Sentiment Rating	Neutral News See Recent DVAX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
1/21/2026	Weiss Ratings Not Rated		Reiterated Rating	Sell (D)
12/24/2025	William Blair 2 of 5 stars	Matt Phipps Not Rated	Downgrade	Outperform ➝ Hold
8/22/2025	Citizens Jmp 4 of 5 stars	Roy Buchanan 2 of 5 stars	Reiterated Rating	Market Outperform	$32.00	+192.24%
4/17/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Choi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sell	$12.00 ➝ $10.00	-3.61%
2/21/2025	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward White Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$31.00 ➝ $31.00	+132.47%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 04:32 AM ET.

DVAX Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Dynavax Technologies is $32.00, with a high forecast of $32.00 and a low forecast of $32.00.
: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dynavax Technologies in the last year. There is currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DVAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DVAX, but not buy additional shares or sell existing shares.
: According to analysts, Dynavax Technologies's stock has a predicted upside of 106.45% based on their 12-month stock forecasts.
: Analysts like Dynavax Technologies less than other "medical" companies. The consensus rating score for Dynavax Technologies is 2.00 while the average consensus rating score for "medical" companies is 2.30. Learn more on how DVAX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Dynavax Technologies Recommendations

This page (NASDAQ:DVAX) was last updated on 5/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.